TITLE

Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes

AUTHOR(S)
HANDELSMAN, YEHUDA
PUB. DATE
May 2011
SOURCE
Diabetes Care;May2011 Supplement 2, Vol. 34, pS244
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the rationale for the use of a bile acid sequestrant (BAS) to treat type 2 diabetes. It describes the clinical effects of the BAS, known as colesevelam hydrochloride, that has been approved for both glycemic and lipid control in the U.S. As new agents are approved in the market, the treatment strategies for type 2 diabetes also changed. Example of oral anti-diabetes agents include biguanides, BAS, and dipeptidyl peptidase-4 inhibitors. Aside from BAS, other lipid-lowering agents used to treat hypercholesterolemia are listed.
ACCESSION #
61968019

 

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics